leukemia
The high-coverage whole-genome assay is covered for patients with myeloid neoplasms, including acute myeloid leukemia and myelodysplastic syndrome.
The Swedish bioinformatics firm is targeting February 2025 for regulatory approval of its Qlucore Diagnostics software for transcriptomics-based ALL testing.
Invivoscribe Gets FDA Approval for LeukoStrat CDx for Daiichi Sankyo Leukemia Drug
The PCR-based test detects internal tandem duplication and tyrosine kinase domain mutations D835 and I836 in the FLT3 gene.
Cepheid Nabs CE-IVD Mark for Molecular NPM1 Mutation Test for AML Monitoring
The test quantifies mutant NPM1 mRNA transcripts in peripheral blood specimens from patients with acute myeloid leukemia.
Invivoscribe Leukemia CDx Assay Nabs IVDR Approval
The PCR-based test detects internal tandem duplications and tyrosine kinase domain mutations D835 and I836 in the FLT3 gene in patients with acute myelogenous leukemia.